Laura M Sanftner

Summary

Affiliation: Avigen Inc
Country: USA

Publications

  1. ncbi request reprint Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAV
    Laura M Sanftner
    Avigen, Inc, Alameda, CA 94502, USA
    Mol Ther 9:403-9. 2004
  2. pmc AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters
    Laura M Sanftner
    Avigen Inc, 1301 Harbor Bay Parkway, Alameda, CA 94502, USA
    Exp Neurol 194:476-83. 2005
  3. ncbi request reprint Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned rats
    Laura M Sanftner
    Avigen, Inc, 1301 Harbor Bay Parkway, Alameda, CA 94502, USA
    Mol Ther 13:167-74. 2006
  4. pmc The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain
    Annemarie Ledeboer
    Department of Preclinical Development, Avigen Inc, Alameda, CA 94502, USA
    Neuron Glia Biol 2:279-91. 2006
  5. pmc A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys
    John R Forsayeth
    Department of Neurosurgery, University of California at San Francisco, Room MCB 226, 1855 Folsom Street, San Francisco, CA 94103-0555, USA
    Mol Ther 14:571-7. 2006

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAV
    Laura M Sanftner
    Avigen, Inc, Alameda, CA 94502, USA
    Mol Ther 9:403-9. 2004
    ..These results have important implications for gene therapy for CNS disorders...
  2. pmc AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters
    Laura M Sanftner
    Avigen Inc, 1301 Harbor Bay Parkway, Alameda, CA 94502, USA
    Exp Neurol 194:476-83. 2005
    ....
  3. ncbi request reprint Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned rats
    Laura M Sanftner
    Avigen, Inc, 1301 Harbor Bay Parkway, Alameda, CA 94502, USA
    Mol Ther 13:167-74. 2006
    ..Recombinant AAV vectors controlled by rapamycin or its analogs show promise as candidates for CNS therapies in which regulation of the transgene is desired...
  4. pmc The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain
    Annemarie Ledeboer
    Department of Preclinical Development, Avigen Inc, Alameda, CA 94502, USA
    Neuron Glia Biol 2:279-91. 2006
    ..Overall, the results indicate that AV411 is effective in diverse models of neuropathic pain and support further exploration of its potential as a therapeutic agent for the treatment of neuropathic pain...
  5. pmc A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys
    John R Forsayeth
    Department of Neurosurgery, University of California at San Francisco, Room MCB 226, 1855 Folsom Street, San Francisco, CA 94103-0555, USA
    Mol Ther 14:571-7. 2006
    ..These findings have implications for the design and interpretation of clinical studies of AAV-hAADC gene therapy...